Corporate ManufacturerCached Profile
JANSSEN SCIENTIFIC AFFAIRS
Manufacturer Corporate ID: 100000000332
Subsidiaries Logged: 2 entities
LIFETIME CORPORATE SPEND
$4,331,873
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. NEIL LOVEMedical Doctor
$540,0002. Dr. ANTHONY TURKIEWICZMedical Doctor
$86,8673. Dr. ARTHUR KORNBLUTHMedical Doctor
$63,2884. Dr. AMAR MAJJHOOMedical Doctor
$54,8005. Dr. BINCY ABRAHAMMedical Doctor
$48,942Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. TREMFYA$1,369,655 (31.6%)
2. SPRAVATO$961,300 (22.2%)
3. STELARA$277,624 (6.4%)
4. RYBREVANT$100,396 (2.3%)
5. SIMPONI ARIA$97,038 (2.2%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
JANSSEN PHARMACEUTICALS, INCJANSSEN SCIENTIFIC AFFAIRS, LLC
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for JANSSEN SCIENTIFIC AFFAIRS...